Last 12 months
Inside the activity.
1 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2025 Filed Jun 11, 2025 21:14 UTC |
ROGERS MICHAEL WDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001562180-25-004720 · primarydocument.xml · derivative · entry 2 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2035-06-10 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:14 UTC |
ROGERS MICHAEL WDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004720 · primarydocument.xml · nonDerivative · entry 1 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,729 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:16 UTC |
ZUMWALT LEANNE MDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001562180-25-004724 · primarydocument.xml · derivative · entry 2 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2035-06-10 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:16 UTC |
ZUMWALT LEANNE MDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004724 · primarydocument.xml · nonDerivative · entry 1 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,400 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 17:14 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001562180-25-004719 · primarydocument.xml · derivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2035-06-10 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 17:14 UTC |
GILMAN STEVEN CDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004719 · primarydocument.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,830 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:15 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001562180-25-004721 · primarydocument.xml · derivative · entry 2 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2035-06-10 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:15 UTC |
Smith CynthiaDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004721 · primarydocument.xml · nonDerivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,933 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:13 UTC |
FRIESON RONDirector
|
GrantStock Option (Right to buy) · Derivative | 53,600 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001562180-25-004718 · primarydocument.xml · derivative · entry 2 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,600 Underlying: Common Stock · 53,600 shares Expires 2035-06-10 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:13 UTC |
FRIESON RONDirector
|
GrantCommon Stock | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004718 · primarydocument.xml · nonDerivative · entry 1 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,500 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:13 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
Exercise / conversionStock Option (Right to buy) · Derivative | 15,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001562180-25-004717 · primarydocument.xml · derivative · entry 3 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 321,000 Underlying: Common Stock · 15,000 shares Expires 2034-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This stock option exercise was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the reporting person on December 12, 2024. F4 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:13 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
SaleCommon Stock | 15,000 | $4.01 | $60,150.00 |
DisclosureSEC source: 0001562180-25-004717 · primarydocument.xml · nonDerivative · entry 2 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 266,914 F2 · shares: This sale was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the reporting person on December 12, 2024. F3 · price: The shares were sold at prices ranging from $4.00 to $4.03 and the price reported reflects the weighted average sale price. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:13 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 15,000 | $1.68 | $25,200.00 |
DisclosureSEC source: 0001562180-25-004717 · primarydocument.xml · nonDerivative · entry 1 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 281,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This stock option exercise was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the reporting person on December 12, 2024. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:35 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
SaleCommon Stock | 13,334 | $3.53 | $47,069.02 |
DisclosureSEC source: 0001562180-25-004491 · primarydocument.xml · nonDerivative · entry 1 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 266,914 F1 · shares: This sale was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the Reporting Person on December 12, 2024. F2 · price: The shares were sold at prices ranging from $3.50 to $3.60 and the price reported reflects the weighted average sale price. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:05 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 46,409 | $1.83 | $84,928.47 |
DisclosureSEC source: 0001562180-25-001998 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,557,921 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:04 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 7,144 | $1.83 | $13,073.52 |
DisclosureSEC source: 0001562180-25-001997 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 809,090 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:54 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 97,982 | $2.10 | $205,762.20 |
DisclosureSEC source: 0001562180-25-000917 · primarydocument.xml · nonDerivative · entry 3 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,604,330 F3 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2023. F5 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:54 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 46,268 | $2.10 | $97,162.80 |
DisclosureSEC source: 0001562180-25-000917 · primarydocument.xml · nonDerivative · entry 2 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,702,312 F3 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2023. F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:53 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 27,236 | $2.10 | $57,195.60 |
DisclosureSEC source: 0001562180-25-000916 · primarydocument.xml · nonDerivative · entry 3 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 816,234 F4 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. F5 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:53 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 23,270 | $2.10 | $48,867.00 |
DisclosureSEC source: 0001562180-25-000916 · primarydocument.xml · nonDerivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 843,470 F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023. F4 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:52 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
SaleCommon Stock | 30,202 | $2.10 | $63,424.20 |
DisclosureSEC source: 0001562180-25-000915 · primarydocument.xml · nonDerivative · entry 2 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280,248 F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. F4 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2023. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:51 UTC |
Grund NicholasChief Commercial Officer
|
SaleCommon Stock | 55,621 | $2.10 | $116,804.10 |
DisclosureSEC source: 0001562180-25-000914 · primarydocument.xml · nonDerivative · entry 2 Grund Nicholas · CIK 0001661887 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 442,579 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. F3 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2024. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:54 UTC |
Butler John P.Director · CEO and President
|
GrantStock Option (Right to buy) · Derivative | 1,051,400 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001562180-25-000917 · primarydocument.xml · derivative · entry 9 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,051,400 Underlying: Common Stock · 1,051,400 shares Expires 2035-01-31 F7 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:54 UTC |
Butler John P.Director · CEO and President
|
GrantPerformance Stock Units · Derivative | 350,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000917 · primarydocument.xml · derivative · entry 8 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350,500 Underlying: Common Stock · 350,500 shares Expires 2027-01-31 F6 · derivative.exercise_price: Each Performance Stock Unit ("PSU") right represents a contingent right to receive one share of the Issuer's common stock. One-half of the total number of shares of common stock underlying the PSUs shall vest on each of (a) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $3.50 over a 30-day trading period, and (b) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $5.00 for over a 30-day trading period, subject to the reporting person's continued service with the Issuer through the applicable vesting date. F6 · derivative.exercise_date: Each Performance Stock Unit ("PSU") right represents a contingent right to receive one share of the Issuer's common stock. One-half of the total number of shares of common stock underlying the PSUs shall vest on each of (a) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $3.50 over a 30-day trading period, and (b) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $5.00 for over a 30-day trading period, subject to the reporting person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:54 UTC |
Butler John P.Director · CEO and President
|
GrantCommon Stock | 701,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000917 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,748,580 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 28, 2024 and 1,500 shares of the Issuer's common stock purchased on December 31, 2024, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:53 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantStock Option (Right to buy) · Derivative | 292,300 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001562180-25-000916 · primarydocument.xml · derivative · entry 4 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,300 Underlying: Common Stock · 292,300 shares Expires 2035-01-31 F6 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:53 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantCommon Stock | 194,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000916 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 866,740 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 28, 2024 and 1,500 shares of the Issuer's common stock purchased on December 31, 2024, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:52 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
GrantStock Option (Right to buy) · Derivative | 128,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001562180-25-000915 · primarydocument.xml · derivative · entry 3 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,000 Underlying: Common Stock · 128,000 shares Expires 2035-01-31 F5 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:52 UTC |
Malabre Richard CSVP, Chief Accounting Officer
|
GrantCommon Stock | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000915 · primarydocument.xml · nonDerivative · entry 1 Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 310,450 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on December 31, 2024 under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:51 UTC |
Grund NicholasChief Commercial Officer
|
GrantStock Option (Right to buy) · Derivative | 292,300 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001562180-25-000914 · primarydocument.xml · derivative · entry 3 Grund Nicholas · CIK 0001661887 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,300 Underlying: Common Stock · 292,300 shares Expires 2035-01-31 F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:51 UTC |
Grund NicholasChief Commercial Officer
|
GrantCommon Stock | 194,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000914 · primarydocument.xml · nonDerivative · entry 1 Grund Nicholas · CIK 0001661887 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 498,200 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:48 UTC |
Ostrowski ErikSVP, CFO, CBO & Treasurer
|
GrantStock Option (Right to buy) · Derivative | 292,300 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001562180-25-000913 · primarydocument.xml · derivative · entry 2 Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,300 Underlying: Common Stock · 292,300 shares Expires 2035-01-31 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:48 UTC |
Ostrowski ErikSVP, CFO, CBO & Treasurer
|
GrantCommon Stock | 194,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000913 · primarydocument.xml · nonDerivative · entry 1 Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544,900 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 21:06 UTC |
FRIESON RONDirector
|
Exercise / conversionStock Option (Right to buy) · Derivative | 20,100 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-25-000453 · primarydocument.xml · derivative · entry 2 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,100 shares Expires 2032-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 21:06 UTC |
FRIESON RONDirector
|
Exercise / conversionCommon Stock | 20,100 | $0.45 | $9,045.00 |
DisclosureSEC source: 0001562180-25-000453 · primarydocument.xml · nonDerivative · entry 1 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:31 UTC |
Ostrowski ErikSVP, CFO, CBO & Treasurer
|
GrantStock Option (Right to buy) · Derivative | 500,000 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001562180-24-005516 · primarydocument.xml · derivative · entry 2 Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2034-06-28 F2 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each vesting date. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:31 UTC |
Ostrowski ErikSVP, CFO, CBO & Treasurer
|
GrantCommon Stock | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005516 · primarydocument.xml · nonDerivative · entry 1 Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the RSUs will vest upon each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer on each vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:20 UTC |
Wolf MylesDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001562180-24-004910 · primarydocument.xml · derivative · entry 2 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:20 UTC |
Wolf MylesDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004910 · primarydocument.xml · nonDerivative · entry 1 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,681 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:18 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001562180-24-004901 · primarydocument.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:18 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004901 · primarydocument.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,800 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:19 UTC |
ROGERS MICHAEL WDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001562180-24-004907 · primarydocument.xml · derivative · entry 2 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:19 UTC |
ROGERS MICHAEL WDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004907 · primarydocument.xml · nonDerivative · entry 1 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,029 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:18 UTC |
ZUMWALT LEANNE MDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001562180-24-004904 · primarydocument.xml · derivative · entry 2 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:18 UTC |
ZUMWALT LEANNE MDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004904 · primarydocument.xml · nonDerivative · entry 1 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,700 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 16:19 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001562180-24-004906 · primarydocument.xml · derivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 16:19 UTC |
GILMAN STEVEN CDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004906 · primarydocument.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,130 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:20 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001562180-24-004909 · primarydocument.xml · derivative · entry 2 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:20 UTC |
Smith CynthiaDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004909 · primarydocument.xml · nonDerivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,233 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:19 UTC |
FRIESON RONDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001562180-24-004905 · primarydocument.xml · derivative · entry 2 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.